Article (Transfusion -- March 8, 2012): The United States Trypanosoma cruzi Infection Study: Evidence for Vector-borne Transmission of the Parasite That Causes Chagas Disease Among United States Blood Donors.
The ALS Association says the average lifespan of someone diagnosed with the condition is between two and five years. More than 50 percent make it past year three. Twenty percent make it past year five. From there, the number plummets. Less than 5 percent make it past two decades.
Using the new treatment, researchers were able to stop the progression of ALS in one type of transgenic mouse model, which ordinarily would die within two weeks without treatment. Some of these mice have survived for more than 650 days, 500 days longer than any previous research has been able to achieve.